Atlas Trials

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Clinical trial NCT06791083 · RECRUITING

Trial details

NCT number
NCT06791083
Sponsor
First Affiliated Hospital of Fujian Medical University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2024-06-20
Primary completion
2025-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.